Gould Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Buy
1,597
+34
+2% +$34.5K 0.26% 51
2025
Q4
$1.68M Sell
1,563
-5
-0.3% -$4.78K 0.3% 46
2025
Q3
$1.2M Hold
1,568
0.22% 53
2025
Q2
$1.22M Buy
1,568
+1,020
+186% +$793K 0.24% 52
2025
Q1
$453K Hold
548
0.09% 104
2024
Q4
$423K Sell
548
-76
-12% -$62.9K 0.09% 107
2024
Q3
$553K Sell
624
-39
-6% -$35.1K 0.12% 91
2024
Q2
$600K Buy
663
+39
+6% +$31.2K 0.14% 82
2024
Q1
$485K Hold
624
0.12% 92
2023
Q4
$364K Hold
624
0.09% 111
2023
Q3
$335K Buy
624
+8
+1% +$4.12K 0.09% 105
2023
Q2
$289K Hold
616
0.08% 116
2023
Q1
$212K Hold
616
0.06% 138
2022
Q4
$225K Buy
+616
New +$218K 0.07% 135
2022
Q3
Sell
-616
Closed -$200K 140
2022
Q2
$200K Buy
+616
New +$185K 0.06% 135

Other funds holding LLY

Gould Asset Management's LLY Position: Q1 2026 in Review

Gould Asset Management increased its Eli Lilly (LLY) stake by 2.2% in Q1 2026, buying an estimated $34.5K and bringing the position to 1,597 shares worth $1.47M. The position accounts for 0.26% of the portfolio, ranked #51.

Gould Asset Management first reported a position in LLY in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.68M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Gould Asset Management held 1,597 shares of Eli Lilly worth $1.47M as of Q1 2026.
  • Gould Asset Management bought 34 Eli Lilly shares in Q1 2026, an estimated $34.5K.
  • Eli Lilly made up 0.26% of Gould Asset Management's portfolio in Q1 2026, its #51 holding.
  • Gould Asset Management first reported a position in Eli Lilly in Q2 2022 and has held it in 15 quarters since.
  • Gould Asset Management's Eli Lilly position peaked at $1.68M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gould Asset Management's 13F filing for Q1 2026, filed 6 May 2026.